These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24054956)

  • 1. Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation.
    Shariff N; Desai RV; Patel K; Ahmed MI; Fonarow GC; Rich MW; Aban IB; Banach M; Love TE; White M; Aronow WS; Epstein AE; Ahmed A
    Am J Med; 2013 Oct; 126(10):887-93. PubMed ID: 24054956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
    Gheorghiade M; Fonarow GC; van Veldhuisen DJ; Cleland JG; Butler J; Epstein AE; Patel K; Aban IB; Aronow WS; Anker SD; Ahmed A
    Eur Heart J; 2013 May; 34(20):1489-97. PubMed ID: 23592708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO; Marzouka GR; Rathod AD; Patel NJ; Myerburg RJ; Mitrani RD
    Am J Cardiol; 2013 Jun; 111(12):1759-63. PubMed ID: 23540545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of treatment crossovers on clinical outcomes in the rate and rhythm control strategies for atrial fibrillation: Insights from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial.
    Maan A; Zhang Z; Qin Z; Wang Y; Dudley S; Dabhadakar K; Refaat M; Mansour M; Ruskin JN; Heist EK
    Pacing Clin Electrophysiol; 2017 Jul; 40(7):770-778. PubMed ID: 28543286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
    Gillinov AM; Bagiella E; Moskowitz AJ; Raiten JM; Groh MA; Bowdish ME; Ailawadi G; Kirkwood KA; Perrault LP; Parides MK; Smith RL; Kern JA; Dussault G; Hackmann AE; Jeffries NO; Miller MA; Taddei-Peters WC; Rose EA; Weisel RD; Williams DL; Mangusan RF; Argenziano M; Moquete EG; O'Sullivan KL; Pellerin M; Shah KJ; Gammie JS; Mayer ML; Voisine P; Gelijns AC; O'Gara PT; Mack MJ;
    N Engl J Med; 2016 May; 374(20):1911-21. PubMed ID: 27043047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).
    Camm AJ; Breithardt G; Crijns H; Dorian P; Kowey P; Le Heuzey JY; Merioua I; Pedrazzini L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
    J Am Coll Cardiol; 2011 Jul; 58(5):493-501. PubMed ID: 21777747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
    Williams ES; Thompson VP; Chiswell KE; Alexander JH; White HD; Ohman EM; Al-Khatib SM
    Cardiol J; 2013; 20(4):439-46. PubMed ID: 23913464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    Kim D; Yang PS; You SC; Sung JH; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Joung B
    BMJ; 2021 May; 373():n991. PubMed ID: 33975876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.
    Carlsson J; Miketic S; Windeler J; Cuneo A; Haun S; Micus S; Walter S; Tebbe U;
    J Am Coll Cardiol; 2003 May; 41(10):1690-6. PubMed ID: 12767648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between the Use of Antiarrhythmic Drugs in Non-Valvular Atrial Fibrillation and Patient Prognosis Using Data from the China Atrial Fibrillation (China-AF) Registry.
    Hou XX; Du X; Zheng D; Li YM; He L; Li XX; Dong JZ
    Med Sci Monit; 2019 Jun; 25():4856-4868. PubMed ID: 31256190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Steinberg JS; Sadaniantz A; Kron J; Krahn A; Denny DM; Daubert J; Campbell WB; Havranek E; Murray K; Olshansky B; O'Neill G; Sami M; Schmidt S; Storm R; Zabalgoitia M; Miller J; Chandler M; Nasco EM; Greene HL
    Circulation; 2004 Apr; 109(16):1973-80. PubMed ID: 15051639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhythm control versus rate control for atrial fibrillation and heart failure.
    Roy D; Talajic M; Nattel S; Wyse DG; Dorian P; Lee KL; Bourassa MG; Arnold JM; Buxton AE; Camm AJ; Connolly SJ; Dubuc M; Ducharme A; Guerra PG; Hohnloser SH; Lambert J; Le Heuzey JY; O'Hara G; Pedersen OD; Rouleau JL; Singh BN; Stevenson LW; Stevenson WG; Thibault B; Waldo AL;
    N Engl J Med; 2008 Jun; 358(25):2667-77. PubMed ID: 18565859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy.
    Andrade JG; Roy D; Wyse DG; Tardif JC; Talajic M; Leduc H; Tourigny JC; Shohoudi A; Dubuc M; Rivard L; Guerra PG; Thibault B; Dyrda K; Macle L; Khairy P
    Heart Rhythm; 2016 Jan; 13(1):54-61. PubMed ID: 26299677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of rhythm versus rate control in atrial fibrillation.
    Marshall DA; Levy AR; Vidaillet H; Fenwick E; Slee A; Blackhouse G; Greene HL; Wyse DG; Nichol G; O'Brien BJ;
    Ann Intern Med; 2004 Nov; 141(9):653-61. PubMed ID: 15520421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation.
    Ionescu-Ittu R; Abrahamowicz M; Jackevicius CA; Essebag V; Eisenberg MJ; Wynant W; Richard H; Pilote L
    Arch Intern Med; 2012 Jul; 172(13):997-1004. PubMed ID: 22664954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.